XML 88 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
Statements of Consolidated Income (USD $)
In Millions, except Share data in Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2009
Net sales $ 1,301.3 [1] $ 1,079.1 $ 987.0
Cost of products sold:      
Cost of products sold, excluding depreciation, amortization, and other items 1,158.9 946.8 766.4
Lower of cost or market inventory write-down 0 0 9.3
Impairment of investment in Anglesey 0 0 1.8
Restructuring costs and other (benefits) charges (0.3) (0.3) 5.4
Depreciation and amortization 25.2 19.8 16.4
Selling, administrative, research and development, and general 62.7 67.7 69.9
Other operating (benefits) charges, net (0.2) 4.0 (0.9)
Total costs and expenses 1,246.3 1,038.0 868.3
Operating income 55.0 41.1 118.7
Other (expense) income:      
Interest expense (18.0) (11.8) 0
Other income (expense), net 4.3 (4.2) (0.1)
Income before income taxes 41.3 25.1 118.6
Income tax provision (16.2) (13.1) (48.1)
Net income $ 25.1 [1] $ 12.0 $ 70.5
Earnings per common share, Basic:      
Net income per share $ 1.32 [1] $ 0.61 $ 3.51
Earnings per common share, Diluted:      
Net income per share $ 1.32 [1] $ 0.61 $ 3.51
Weighted-average number of common shares outstanding (000):      
Basic 18,979 [2] 19,377 [2] 19,639 [2]
Diluted 18,979 [2] 19,377 [2] 19,639 [2]
[1] The combined results presented for year ended December 31, 2011 are the actual results presented in the Statements of Consolidated Income, as the operating results for the Chandler, Arizona (Extrusion) facility were included in the Company's consolidated operating results commencing January 1, 2011 (see Note 1).
[2] The basic weighted-average number of common shares outstanding during the period excludes unvested share-based payment awards. The diluted weighted-average number of common shares outstanding during the period is calculated under the two-class method, which does not take into account the dilutive effect of the unvested share-based payment awards.